Santé log

TRexBio Announces Pricing of Initial Public Offering

(“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today announced the pricing of its ...
Santé log

Retension Pharmaceuticals Announces Pricing of Initial Public Offering

Retension Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. The Company’s lead clinical ...
Santé log

Zoumalan, MD FACS Inc. Introduces the Bella Lift, an Upper Face Rejuvenation That Treats the Brow and Eyelids Together

The Bella Lift places incisions within the hairline, the natural eyelid crease and the inside of the lower eyelid, and most patients return to work within about two weeks. Candidacy, recovery and ...
Santé log

Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet

NDA and MAA of deucrictibant IR for the on-demand treatment of HAE attacks under review by regulatory authorities ZUG, Switzerland, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a ...
Santé log

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

Each year, CMS assigns Star ratings to Medicare Advantage and Part D contracts on its healthcare quality and drug plan, and issues a Star rating on a scale of 1 to 5 Stars. These ratings affect ...
Santé log

Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies

Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced interim data from its Phase 1 clinical trial of ER-100 ...
Santé log

Echosens to Address GLP-1 Costs and Metabolic Health at SIIA National Conference 2026, Highlight Opportunities for Self-Insured Stakeholders and On-Site Clinics

The panel, taking place Tuesday, Oct. 13, from 10:15–11:30 a.m. MST during the Self-Insurance Institute of America (SIIA) National Conference 2026 in Phoenix, will explore strategies for managing ...
Opinion
Santé logOpinion

Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts in CMS 2027 Star Ratings

The company also reported that its California H3815 HMO contract received a 3.5-Star Rating for 2027. Alignment believes the rating does not accurately reflect the contract’s longstanding performance ...
Santé log

NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026

NovaBridge Biosciences (NASDAQ: NBP) today announced that updated results from the Phase 1b combination study of givastomig, a Claudin 18.2 (CLDN18.2) x 4-1BB bispecific antibody, in combination with ...
Santé log

Clever Care Health Plan Achieves 4.5-Star Medicare Advantage Rating from CMS for Star Year 2027

Clever Care’s star rating reflects the health plan’s focus on quality, member experience, and better health outcomes, which are demonstrated by its new 2027 benefits package and its 4-star rating for ...
Santé log

Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation

Data of STENOVA Phase 2a study with ontunisertib in Fibrostenosing Crohn’s disease (FSCD) selected for oral presentation at UEG Week 2026 ---- Resu ...
Santé log

XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout

Clinical Trial Application planned for filing with Health Canada, extending the Company’s international regulatory strategy for gout program XRx-026 ● CALGARY, Alberta, Oct. 08, 2026 (GLOBE NEWSWIRE) ...